These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1989349)

  • 1. Cyclophilin binding: a more accurate measure of cyclosporine immunosuppressive activity after renal transplantation.
    Paul K; Harding MW; Marks WH; Handschumacher RE; Lorber MI
    Transplant Proc; 1991 Feb; 23(1 Pt 2):974-5. PubMed ID: 1989349
    [No Abstract]   [Full Text] [Related]  

  • 2. A natural specific intracellular ligand as a reagent for cyclosporine blood level determination.
    Hasková V; Rozprimová L; Svobodová J
    Folia Biol (Praha); 1991; 37(2):134-9. PubMed ID: 1874341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophilins and immunosuppression by cyclosporins and macrolide structures.
    Schreier MH
    Acta Derm Venereol Suppl (Stockh); 1994; 186():100. PubMed ID: 7521103
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity.
    Quesniaux VF; Schreier MH; Wenger RM; Hiestand PC; Harding MW; Van Regenmortel MH
    Eur J Immunol; 1987 Sep; 17(9):1359-65. PubMed ID: 3308488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of ciclosporin levels using a ciclophilin-binding assay.
    Steiner G; Mayer G; Woloszczuk W
    Bibl Cardiol; 1988; (43):46-56. PubMed ID: 3067723
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of cyclosporine by a competitive binding assay with cyclophilin.
    Steiner G; Küllinger B; Mayer G; Jie Y; Leibl H; Kovarik J; Woloszczuk W
    Clin Chem; 1991 Mar; 37(3):403-10. PubMed ID: 2004448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomerase modification.
    Rakitzis ET
    Nature; 1989 Aug; 340(6232):351-2. PubMed ID: 2666859
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin G and metabolite binding to cyclophilin and a 50-kDa binding protein related to in vitro immunosuppression.
    Donnelly JG; Chen Y; Yatscoff RW; Copeland KR; Palaszynski EW; Soldin SJ
    Clin Chem; 1993 Jan; 39(1):122-5. PubMed ID: 8419033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of cyclosporine and metabolite binding to cyclophilin and a 50 kDa binding protein with in vitro immunosuppression: a preliminary report.
    Donnelly JG; Russell RL; Palaszynski EW; Copeland KR; Yatscoff RW; Chan MM; Soldin SJ
    Clin Biochem; 1991 Feb; 24(1):71-4. PubMed ID: 2060135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin A.
    Ryffel B; Woerly G; Murray M; Eugster HP; Car B
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1074-83. PubMed ID: 8394698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine-cyclophilin interaction.
    Quesniaux VF; Schreier MH; Wenger RM; Hiestand PC; Van Regenmortel MH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):58-62. PubMed ID: 3284106
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification and characterization of human T-cell cyclophilin expressed in Escherichia coli.
    Levy MA; Brandt M; Livi GP; Bergsma DJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):319-22. PubMed ID: 1990542
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues.
    Durette PL; Boger J; Dumont F; Firestone R; Frankshun RA; Koprak SL; Lin CS; Melino MR; Pessolano AA; Pisano J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):51-7. PubMed ID: 2966482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional features of the peptidyl prolyl cis-trans isomerase, cyclophilin.
    Harding MW
    Pharmacotherapy; 1991; 11(6):142S-148S. PubMed ID: 1771139
    [No Abstract]   [Full Text] [Related]  

  • 16. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin.
    Takahashi N; Hayano T; Suzuki M
    Nature; 1989 Feb; 337(6206):473-5. PubMed ID: 2644542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved binding affinity for cyclophilin A by a cyclosporin derivative singly modified at its effector domain.
    Papageorgiou C; Florineth A; Mikol V
    J Med Chem; 1994 Oct; 37(22):3674-6. PubMed ID: 7966126
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppression. Binding by design.
    Ringe D
    Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
    [No Abstract]   [Full Text] [Related]  

  • 19. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.
    Fischer G; Wittmann-Liebold B; Lang K; Kiefhaber T; Schmid FX
    Nature; 1989 Feb; 337(6206):476-8. PubMed ID: 2492638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.